ABAD Directly Links Aß to Mitochondrial Toxicity in Alzheimer's Disease
The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Abstract
Mitochondrial dysfunction is a hallmark of β-amyloid (Aβ)–induced neuronal toxicity in Alzheimer's disease (AD). Here, we demonstrate that Aβ-binding alcohol dehydrogenase (ABAD) is a direct molecular link from Aβ to mitochondrial toxicity. Aβ interacts with ABAD in the mitochondria of AD patients and transgenic mice. The crystal structure of Aβ-bound ABAD shows substantial deformation of the active site that prevents nicotinamide adenine dinucleotide (NAD) binding. An ABAD peptide specifically inhibits ABAD-Aβ interaction and suppresses Aβ-induced apoptosis and free-radical generation in neurons. Transgenic mice overexpressing ABAD in an Aβ-rich environment manifest exaggerated neuronal oxidative stress and impaired memory. These data suggest that the ABAD-Aβ interaction may be a therapeutic target in AD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Additionally, Aβ interacts specifically with mitochondrial Aβ-binding alcohol dehydrogenase (ABAD), impeding the binding of NAD to ABAD and inducing ROS production.287,288”
From Recent advances in Alzheimer's disease: Mechanisms, clinical trials and new drug development strategies. (2024) · cites this paper as [287]
In the citing paper
“A number of studies have associated intraneuronal Ab buildup with hyperphosphorylation of tau protein, 8 disturbed protein trafficking and sorting, 9 reduced expression of synaptic proteins, 10 and mitochondrial dysfunction.11,12”
From Blocking the Interaction between Apolipoprotein E and Aβ Reduces Intraneuronal Accumulation of Aβ and Inhibits Synaptic Degeneration (2013) · cites this paper as [11]
In the citing paper
“Aβ, and its precursor APP, localize, in part, to mitochondria in which they can cause mitochondrial dysfunction as evidenced by increased production of RS, enzyme inhibition, loss of cytochrome c, and depolarization of Δψm (Casley et al., 2002a; Kim et al., 2002; Anandatheerthavarada et al., 2003; Jang and Surh, 2003; Lustbader et al., 2004; Liang et al., 2009; Takuma et al., 2009).”
From The mitochondria-targeted antioxidant MitoQ prevents loss of spatial memory retention and early neuropathology in a transgenic mouse model of Alzheimer’s disease (2011) · cites this paper as Lustbader et al., 2004
In the citing paper
“Aβ is reported to increase RS in neurons via multiple mechanisms, including direct Aβ-induced RS production, elevated NADPH oxidase activity, interaction with mitochondria-associated Aβ alcohol dehydrogenase, inhibition of cytochrome oxidase (respiratory complex IV), and by causing leakage of electrons from the mitochondrial electron transport chain (Hensley et al., 1994; Canevari et al., 1999; L”
From The mitochondria-targeted antioxidant MitoQ prevents loss of spatial memory retention and early neuropathology in a transgenic mouse model of Alzheimer’s disease (2011) · cites this paper as Lustbader et al., 2004
In the citing paper
“Intracellular Aβ may then enter the mitochondria in which it induces additional RS and magnifies the metabolic deficit”
From The mitochondria-targeted antioxidant MitoQ prevents loss of spatial memory retention and early neuropathology in a transgenic mouse model of Alzheimer’s disease (2011) · cites this paper as Lustbader et al., 2004
3 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Mucke, L., Masliah, E., Yu, G.-Q., Mallory, M., Rockenstein, E. M., Tatsuno, G., Hu, K., Kholodenko, D., Johnson-Wood, K., & McConlogue, L. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-11-04050.2000 · Cited by 1,856
Aβ peptide vaccination prevents memory loss in an animal model of Alzheimer's disease
Morgan, D., Diamond, D. M., Gottschall, P. E., Ugen, K. E., Dickey, C., Hardy, J., Duff, K., Jantzen, P., DiCarlo, G., Wilcock, D., et al. (2000) · Nature · doi:10.1038/35050116 · Cited by 1,498
Treatment of Ischemic Brain Damage by Perturbing NMDA Receptor- PSD-95 Protein Interactions
Aarts, M., Liu, Y., Liu, L., Besshoh, S., Arundine, M., Gurd, J. W., Wang, Y.-T., Salter, M. W., & Tymianski, M. (2002) · Science · doi:10.1126/science.1072873 · Cited by 999
Rego, A. C., & Oliveira, C. R. (2003) · Neurochemical Research · doi:10.1023/a:1025682611389 · Cited by 472
TAT-Mediated Protein Transduction into Mammalian Cells
Becker-Hapak, M., McAllister, S. S., & Dowdy, S. F. (2001) · Methods · doi:10.1006/meth.2001.1186 · Cited by 384
Du Yan, S., Fu, J., Soto, C., Chen, X., Zhu, H., Al-Mohanna, F., Collison, K., Zhu, A., Stern, E., Saido, T., et al. (1997) · Nature · doi:10.1038/39522 · Cited by 379
Self-citationRole of mitochondrial dysfunction in Alzheimer's disease
Castellani, R., Hirai, K., Aliev, G., Drew, K. L., Nunomura, A., Takeda, A., Cash, A. D., Obrenovich, M. E., Perry, G., & Smith, M. A. (2002) · Journal of Neuroscience Research · doi:10.1002/jnr.10389 · Cited by 364
Mitochondria in Alzheimer's disease
Swerdlow, R. H., & Kish, S. J. (2002) · International review of neurobiology · doi:10.1016/s0074-7742(02)53013-0 · Cited by 126
Role of ERAB/l-3-Hydroxyacyl-coenzyme A Dehydrogenase Type II Activity in Aβ-induced Cytotoxicity
Du Yan, S., Shi, Y., Zhu, A., Fu, J., Zhu, H., Zhu, Y., Gibson, L., Stern, E., Collison, K., Al-Mohanna, F., et al. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.4.2145 · Cited by 120
Self-citationGrill, H. P., Zweier, J. L., Kuppusamy, P., Weisfeldt, M. L., & Flaherty, J. T. (1992) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(92)90457-x · Cited by 108
Self-citation
Research works printed but not linked: 2
- M. A. Abreoet al. U.S. Patent and Trademark Office serial number 931186 (2002) vol. 9.
- We thank D. Eliezer and T. McGraw for helpful discussions K. D'Amico and L. Tong for help with data collection at the Advanced Photon Source and D. Landry for help with the surface plasmon resonance experiment. This work was supported by P50AG08702 AG16736 AG17490 and NS42855 and in part by Speaker's Fund for Biomedical Research and NIH 1K07AG00959. H.W. is a Pew Scholar of biomedical sciences and a Rita Allen Scholar. The atomic coordinates have been deposited in the Protein Data Bank (PDB accession code 1SO8).
Cited by
Items 801–900 of 1,002
Liu, Z., Liu, Q., Zhang, B., Liu, Q., Fang, L., & Gou, S. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c01240 · Cited by 29
Qiao, L., Shen, Y., Zhang, S., Wang, M., Lv, G., Dou, Q., & Li, C. (2023) · BMEMat · doi:10.1002/bmm2.12011 · Cited by 31
Isobe, C., Abe, T., & Terayama, Y. (2009) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000256209 · Cited by 29
Amyloid-β peptide binds to microtubule-associated protein 1B (MAP1B)
Gevorkian, G., González‐Noriega, A., Acero, G., Ordoñez, J., Michalak, C., Munguía, M. E., Govezensky, T., Cribbs, D. H., & Manoutcharian, K. (2007) · Neurochemistry International · doi:10.1016/j.neuint.2007.10.020 · Cited by 34
The value of Arabidopsis research in understanding human disease states
Xu, X. M., & Møller, S. G. (2010) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2010.11.007 · Cited by 33
He, Y., Jia, K., Li, L., Wang, Q., Zhang, S., Du, J., & Du, H. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.03.119 · Cited by 30
Mitochondrial Calcium Signaling as a Therapeutic Target for Alzheimer’s Disease
Wu, A. J., Tong, B. C., Huang, S., Li, M., & Cheung, K. (2019) · Current Alzheimer Research · doi:10.2174/1567205016666191210091302 · Cited by 31
Marques, A. T., Antunes, A., Fernandes, P. A., & Ramos, M. J. (2006) · BMC Genomics · doi:10.1186/1471-2164-7-202 · Cited by 35
The organellar peptidasome, PreP: A journey from Arabidopsis to Alzheimer's disease
Glaser, E. G., & Alikhani, N. (2009) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2009.12.016 · Cited by 32
ROCK2 inhibition: A futuristic approach for the management of Alzheimer’s disease
Mani, S., Jindal, D., Chopra, H., Jha, S. K., Singh, S. K., Ashraf, G. M., Kamal, M., Iqbal, D., Chellappan, D. K., Dey, A., et al. (2022) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2022.104871 · Cited by 29
Mitochondrial dysfunction and Alzheimer's disease: New developments
Mancuso, M., Siciliano, G., Filosto, M., & Murri, L. (2006) · Journal of Alzheimer s Disease · doi:10.3233/jad-2006-9203 · Cited by 28
Jafari, A., Noursadeghi, E., Khodagholi, F., Saghiri, R., Sauvé, R., Aliaghaei, A., & Eliassi, A. (2015) · Experimental Neurology · doi:10.1016/j.expneurol.2014.12.024 · Cited by 30
Mitochondrial dysfunction and Alzheimer's disease: prospects for therapeutic intervention
Lim, J. W., Lee, J., & Pae, A. N. (2020) · BMB Reports · doi:10.5483/bmbrep.2020.53.1.279 · Cited by 28
Anandatheerthavarada, H. Κ., & Devi, L. (2007) · Reviews in the Neurosciences · doi:10.1515/revneuro.2007.18.5.343 · Cited by 29
El Massry, M., Alaeddine, L. M., Ali, L., Saad, C., & Eid, A. A. (2021) · Current Medicinal Chemistry · doi:10.2174/0929867327666200908114902 · Cited by 27
Schmidt, M., Benek, O., Vinklářová, L., Hrabinová, M., Zemanová, L., Chribek, M., Králová, V., Hroch, L., Doležal, R., Lyčka, A., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21062059 · Cited by 27
Self-citationUnderstanding and controlling amyloid aggregation with chirality
Foley, A. R., & Raskatov, J. A. (2021) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2021.01.003 · Cited by 28
Meng, J., Lv, Z., Guo, M., Sun, C., Li, X., Jiang, Z., Zhang, W., & Chen, C. (2022) · The FASEB Journal · doi:10.1096/fj.202101116rr · Cited by 28
Recent advance on pleiotropic cholinesterase inhibitors bearing amyloid modulation efficacy
Zhang, H., Peng, Y., Zhuo, L., Wang, Y., Guo, Z., Wang, S., Long, L., Li, X., & Wang, Z. (2022) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2022.114695 · Cited by 27
Tillement, L., Lecanu, L., & Papadopoulos, V. (2011) · Neurodegenerative Diseases · doi:10.1159/000323264 · Cited by 29
Mitochondria as a target for neuroprotection: implications for Alzheimer´s disease
Cardoso, S., Seiça, R. M., & Moreira, P. I. (2017) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2016.1205488 · Cited by 27
Alzheimer's disease: the role of mitochondrial dysfunction and potential new therapies
Hawking, Z. L. (2016) · Bioscience Horizons The International Journal of Student Research · doi:10.1093/biohorizons/hzw014 · Cited by 31
Zeng, Y., Jun-mei, W., Qu, Z.-Q., Wu, J.-L., & Chung, P. (2017) · Neural Regeneration Research · doi:10.4103/1673-5374.221160 · Cited by 27
Characterization of the interaction between Aβ 1–42 and glyceraldehyde phosphodehydrogenase
Verdier, Y., Földi, I., Sergeant, N., Fülöp, L., Penke, Z., Janáky, T., Szűcs, M., & Penke, B. (2008) · Journal of Peptide Science · doi:10.1002/psc.998 · Cited by 31
Chemical Chaperone and Inhibitor Discovery: Potential Treatments for Protein Conformational Diseases
Zhao, J., Liu, H., Lin, H., Huang, C., Fang, H., Chen, S., Ho, Y., Tsai, W., & Chen, W. (2007) · Perspectives in Medicinal Chemistry · doi:10.4137/pmc.s212 · Cited by 31
Intraneuronal β‐amyloid and its interactions with proteins and subcellular organelles
Penke, B., Tóth, A. M., Földi, I., Szűcs, M., & Janáky, T. (2012) · Electrophoresis · doi:10.1002/elps.201200297 · Cited by 29
Mitochondrial drug targets in neurodegenerative diseases
Lee, J. (2016) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2015.11.032 · Cited by 26
Pathogenic role of mitochondrial amyloid-β peptide
Chen, J. X., & Yan, S. D. (2007) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.7.11.1517 · Cited by 26
Self-citationCarlson, E. A., Marquez, R. T., Du, F., Wang, Y., Xu, L., & Yan, S. S. (2015) · BMC Cancer · doi:10.1186/s12885-015-1173-5 · Cited by 30
Self-citationOxaloacetate decarboxylase FAHD1 – a new regulator of mitochondrial function and senescence
Etemad, S., Petit, M., Weiss, A. K. H., Schrattenholz, A. S., Baraldo, G., & Jansen‐Dürr, P. (2018) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2018.07.007 · Cited by 28
Mehri, S., Barangi, S., Zamiri, E., & Karimi, G. (2020) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-020-01936-9 · Cited by 27
Cacabelos, R. (2004) · Pharmacogenomics · doi:10.1517/14622416.5.8.1049 · Cited by 29
Drug Development in Alzheimer’s Disease: The Contribution of PET and SPECT
Declercq, L., Vandenberghe, R. R., Laere, K. V., Verbruggen, A., & Bormans, G. M. (2016) · Frontiers in Pharmacology · doi:10.3389/fphar.2016.00088 · Cited by 31
A Healthy Heart and a Healthy Brain: Looking at Mitophagy
Luo, H., Zhang, R., Krigman, J., McAdams, A., Ozgen, S., & Sun, N. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00294 · Cited by 25
Unique evolution of foraminiferal calcification to survive global changes
Ujiié, Y., Ishitani, Y., Nagai, Y., Takaki, Y., Toyofuku, T., & Ishii, S. (2023) · Science Advances · doi:10.1126/sciadv.add3584 · Cited by 25
Shi, D. H., Wu, J. H., Ge, H. M., & Tan, R. X. (2009) · Environmental Toxicology and Pharmacology · doi:10.1016/j.etap.2009.01.009 · Cited by 25
Do we age because we have mitochondria?
Bereiter‐Hahn, J. (2013) · PROTOPLASMA · doi:10.1007/s00709-013-0515-x · Cited by 28
In vitro oxidative inactivation of human presequence protease (hPreP)
Teixeira, P. F., Pinho, C. M., Branca, R. M., Lehtiö, J., Levine, R. L., & Glaser, E. G. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.09.039 · Cited by 26
Mitochondria-Targeted Molecules as Potential Drugs to Treat Patients With Alzheimer's Disease
Reddy, A. P., & Reddy, P. H. (2017) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2016.12.010 · Cited by 31
Greene, L. E., Lincoln, R., & Cosa, G. (2018) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2018.04.006 · Cited by 28
What are the threats to successful brain and cognitive aging?
Gallagher, M., Okonkwo, O. C., Resnick, S. M., Jagust, W. J., Benzinger, T. L. S., & Rapp, P. R. (2019) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2019.04.016 · Cited by 28
Essa, H., Peyton, L., Hasan, W., León, B. E., & Choi, D. (2022) · Cells · doi:10.3390/cells11020286 · Cited by 28
Mitochondrial haplogroups associated with Japanese Alzheimer’s patients
Takasaki, S. (2009) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-009-9240-8 · Cited by 25
Sharoar, M. G., Islam, M. R., Shahnawaz, M., Shin, S. Y., & Park, I. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2014.01.008 · Cited by 28
Stefani, M. (2010) · Methods in molecular biology · doi:10.1007/978-1-60761-756-3_2 · Cited by 29
Abid, N. B., Naseer, M. I., & Kim, M. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20051219 · Cited by 26
Role of Mitophagy in neurodegenerative Diseases and potential tagarts for Therapy
Jiao, L., Du, X., Li, Y. H., Jiao, Q., & Jiang, H. F. (2022) · Molecular Biology Reports · doi:10.1007/s11033-022-07738-x · Cited by 25
Maggiore, A., Latina, V., D’Erme, M., Amadoro, G., & Coccurello, R. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102578 · Cited by 25
Hsiao, C., Peng, T., Peng, A. C., Reiter, R. J., Tanaka, M., Lai, Y., & Jou, M. (2012) · Journal of Pineal Research · doi:10.1111/jpi.12004 · Cited by 27
A Tetra(Ethylene Glycol) Derivative of Benzothiazole Aniline Enhances Ras-Mediated Spinogenesis
Megill, A., Lee, T., DiBattista, A. M., Song, J. M., Spitzer, M. H., Rubinshtein, M., Habib, L. K., Capule, C. C., Mayer, M., Turner, R. S., et al. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.1615-12.2013 · Cited by 26
Inhibiting protein–amyloid interactions with small molecules: A surface chemistry approach
Inbar, P., & Yang, J. (2005) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2005.10.067 · Cited by 24
Holzmann, J., & Rossmanith, W. (2009) · Mitochondrion · doi:10.1016/j.mito.2009.03.008 · Cited by 32
Aβ-binding with alcohol dehydrogenase drives Alzheimer's disease pathogenesis: A review
Ye, Z., Liu, Y., Jin, X., Wu, Y., Zhao, H., Gao, T., Deng, Q., Cheng, J., Lin, J., & Tong, Z. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.130580 · Cited by 23
Wallace, J. (2014) · Cell Calcium · doi:10.1016/j.ceca.2014.02.005 · Cited by 24
A quantitative model of human neurodegenerative diseases involving protein aggregation
Kepp, K. P. (2019) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2019.04.001 · Cited by 27
The Beneficial Effect of Mitochondrial Transfer Therapy in 5XFAD Mice via Liver–Serum–Brain Response
Sweetat, S., Nitzan, K., Suissa, N., Haimovich, Y., Lichtenstein, M., Zabit, S., Benhamron, S., Akarieh, K., Mishra, K., Barasch, D., et al. (2023) · Cells · doi:10.3390/cells12071006 · Cited by 23
Um, J., Shin, D. J., Choi, S. M., Nathan, A. B. P., Kim, Y. Y., Lee, D. Y., Jeong, D. J., Kim, D. H., Kim, K. H., Kim, Y. H., et al. (2023) · Theranostics · doi:10.7150/thno.88718 · Cited by 26
Muirhead, K. E. A., Froemming, M. K., Li, X., Musílek, K., Conway, S. J., Sameš, D., & Gunn‐Moore, F. J. (2010) · ACS Chemical Biology · doi:10.1021/cb100199m · Cited by 24
Self-citationKříž, Z., Klusák, J., Krištofíková, Z., & Koča, J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0062914 · Cited by 25
Hopeahainol A attenuates memory deficits by targeting β‐amyloid in APP / PS 1 transgenic mice
Zhu, X., Ye, L., Ge, H. M., Chen, L., Jiang, N., Qian, L., Li, L., Liu, R., Shen, J., Zhang, S., et al. (2012) · Aging Cell · doi:10.1111/acel.12022 · Cited by 23
The Mitochondrion: A Potential Therapeutic Target for Alzheimer’s Disease
Lu, M., Zhao, X., Yao, P.-P., Xu, D.-E., & Ma, Q. (2018) · Neuroscience Bulletin · doi:10.1007/s12264-018-0310-y · Cited by 24
Phosphorylated Amyloid-β: the Toxic Intermediate in Alzheimer’s Disease Neurodegeneration
Milton, N. G. N. (2006) · Springer eBooks · doi:10.1007/0-387-23226-5_20 · Cited by 24
Mitochondrial Regulatory Pathways in the Pathogenesis of Alzheimer’s Disease
Adiele, R. C., & Adiele, C. A. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-150967 · Cited by 23
Traumatic Brain Injury Alters the Metabolism and Facilitates Alzheimer’s Disease in a Murine Model
Lou, D., Du, Y., Huang, D., Cai, F., Zhang, Y. L., Li, T.-Y., Zhou, W., Gao, H., & Song, W. (2017) · Molecular Neurobiology · doi:10.1007/s12035-017-0687-z · Cited by 27
Morsy, A., Krishnaiah, M., Gao, J., Wang, H., Valdez, J., Dow, L. F., Wang, X., & Trippier, P. C. (2022) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.2c00246 · Cited by 23
Jadhav, R., & Kulkarni, Y. A. (2023) · Antioxidants · doi:10.3390/antiox12030707 · Cited by 30
Lee, D., Lee, K., Um, J., Kim, Y.-Y., Kim, D., & Yun, J. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242216542 · Cited by 23
Shi, T., Zhao, D., Wang, H., Feng, S., Liu, S., Xing, J.-H., Qu, Y., Gao, P., Sun, X., & Zhao, M. (2012) · Neurotherapeutics · doi:10.1007/s13311-012-0168-z · Cited by 24
Self-citationMurakami, Y., Ohsawa, I., Kasahara, T., & Ohta, S. (2007) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.07.002 · Cited by 23
Mamada, N., Tanokashira, D., Ishii, K., Tamaoka, A., & Araki, W. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.03.035 · Cited by 23
Aitken, L., Baillie, G. L., Pannifer, A., Morrison, A. J., Jones, P. S., Smith, T., McElroy, S. P., & Gunn‐Moore, F. J. (2017) · SLAS DISCOVERY · doi:10.1177/2472555217697964 · Cited by 23
Self-citationWang, X., Zhao, C.-P., Zhong, L.-C., Zhu, D.-L., Mai, D.-H., Liang, M.-G., & He, M. (2018) · Molecules · doi:10.3390/molecules23123100 · Cited by 22
Hassan, R., Rabea, A. A., Ragae, A., & Sabry, D. (2019) · Archives of Oral Biology · doi:10.1016/j.archoralbio.2019.104596 · Cited by 22
Mondal, S., Vashi, Y., Ghosh, P., Roy, D., Barthakur, M., Kumar, S., & Iyer, P. K. (2020) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.0c00387 · Cited by 22
de Vidania, S., Palomares-Pérez, I., Frank, A., Saito, T., Saido, T. C., Draffin, J. E., Szaruga, M., Chávez‐Gutiérrez, L., Calero, M., Medina, M., et al. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.562581 · Cited by 23
Kwon, B., Gamache, T., Lee, H., & Querfurth, H. W. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2015.05.012 · Cited by 25
Munguía, M. E., Govezensky, T., Martinez, R., Manoutcharian, K., & Gevorkian, G. (2005) · Neuroscience Letters · doi:10.1016/j.neulet.2005.11.061 · Cited by 27
Mechanical stress and formation of protein aggregates in neurodegenerative disorders
Hachiya, N., Kozuka, Y., & Kaneko, K. (2007) · Medical Hypotheses · doi:10.1016/j.mehy.2007.06.043 · Cited by 26
BACE1 activity impairs neuronal glucose oxidation: rescue by beta-hydroxybutyrate and lipoic acid
Findlay, J. A., Hamilton, D. L., & Ashford, M. L. J. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00382 · Cited by 26
Widespread γ-secretase activity in the cell, but do we need it at the mitochondria?
Teng, F. Y. H., & Tang, B. L. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.12.131 · Cited by 21
Decoding Cancer through Silencing the Mitochondrial Gatekeeper VDAC1
Arif, T., Shteinfer‐Kuzmine, A., & Shoshan‐Barmatz, V. (2024) · Biomolecules · doi:10.3390/biom14101304 · Cited by 23
Tapias, V., González-Andrés, P., Fernández-Peña, L., Barbero, A., Núñez, L., & Villalobos, C. (2023) · Antioxidants · doi:10.3390/antiox12061282 · Cited by 23
Jekabsone, A., Jankevičiūtė, S., Pampuščenko, K., Borutaitė, V., & Morkūnienė, R. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241512315 · Cited by 22
Intraneuronal β-amyloid impaired mitochondrial proteostasis through the impact on LONP1
Wang, W., Ma, X., Bhatta, S., Shao, C., Zhao, F., Fujioka, H., Torres, S. L., Wu, F., & Zhu, X. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2316823120 · Cited by 29
Mitochondrial therapeutics in Alzheimer's disease and Parkinson's disease
Hoekstra, J. G., Montine, K. S., Zhang, J., & Montine, T. J. (2011) · Alzheimer s Research & Therapy · doi:10.1186/alzrt83 · Cited by 21
Karim, S., Mirza, Z., Ansari, S. A., Rasool, M., Iqbal, Z., Sohrab, S. S., Kamal, M. A., Abuzenadah, A. M., & Al-Qahtani, M. H. (2014) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527313666140917113446 · Cited by 23
Mechanical stress influences the viability and morphology of human parametrial ligament fibroblasts
Hu, M., Hong, L., Hong, S., Min, J., Zhao, Y., Yang, Q. H., Zhang, Q., Tang, J., & Li, Y. (2016) · Molecular Medicine Reports · doi:10.3892/mmr.2016.6052 · Cited by 21
Diling, C., Yong, T., Jian, Y., Chaoqun, Z., Shuai, O., & Yizhen, X. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00219 · Cited by 24
Liu, L., Chen, S., Yu, M., Ge, C., Ren, M., Liu, B., Yang, X. P., Christian, T., Hou, Y., Zou, J., et al. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-02763-9 · Cited by 23
Microglia-Synapse Pathways: Promising Therapeutic Strategy for Alzheimer’s Disease
Xie, J., Wang, H., Lin, T., & Bi, B. (2017) · BioMed Research International · doi:10.1155/2017/2986460 · Cited by 22
Rofo, F., Sandbaumhüter, F. A., Chourlia, A., Metzendorf, N. G., Morrison, J. I., Syvänen, S., Andrén, P. E., Jansson, E. T., & Hultqvist, G. (2021) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.1c00303 · Cited by 20
Chai, G., Wu, J., Gong, J., Zhou, J.-L., Jiang, Z.-Q., Yi, H., Gu, Y., Huang, H.-H., Yao, Z.-Y., Zhang, Y., et al. (2022) · Neuroscience · doi:10.1016/j.neuroscience.2022.09.020 · Cited by 25
Mitochondrial proteotoxicity: implications and ubiquitin-dependent quality control mechanisms
Karbowski, M., Oshima, Y., & Verhoeven, N. A. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04604-8 · Cited by 23
Evidence that Alzheimer’s Disease Is a Disease of Competitive Synaptic Plasticity Gone Awry
Huang, Z. (2024) · Journal of Alzheimer s Disease · doi:10.3233/jad-240042 · Cited by 21
Nagai, N., & Ito, Y. (2013) · Toxicology · doi:10.1016/j.tox.2013.08.003 · Cited by 21
Nagai, N., Ito, Y., & Sasaki, H. (2016) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.15-19026 · Cited by 22
Boutin, S., Roy, J., Maltais, R., Alata, W., Calon, F., & Poirier, D. (2018) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2018.09.031 · Cited by 21
Jia, K., Tian, J., Wang, T., Guo, L., Xuan, Z., Swerdlow, R. H., & Du, H. (2023) · JCI Insight · doi:10.1172/jci.insight.174290 · Cited by 21
Natural polyphenol: Their pathogenesis-targeting therapeutic potential in Alzheimer's disease
Niu, C., Dong, M., & Niu, Y. (2024) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2024.116359 · Cited by 22
Amyloid‐β in Alzheimer's disease: Structure, toxicity, distribution, treatment, and prospects
Yu, Y., Yu, S., Battaglia, G., & Tian, X. (2024) · Ibrain · doi:10.1002/ibra.12155 · Cited by 38
Metadata
- Authors
- Lustbader, J. W., Cirilli, M., Lin, C., Xu, H. W., Takuma, K., Wang, N., Caspersen, C., Chen, X., Pollak, S., Chaney, M., Trinchese, F., Liu, S., Gunn-Moore, F., Lue, L.-F., Walker, D. G., Kuppusamy, P., Zewier, Z. L., Arancio, O., Stern, D., Yan, S. S., & Wu, H.
- Affiliations
- Harbin Medical University (CN)
- Center for Reproductive Sciences and Department of Obstetrics and Gynecology, College of Physicians and Surgeons, Columbia University, 630 West 168th Street, New York, NY 10032, USA.
- Corresponding author
- Lustbader, Joyce W.
- Cirilli, Maurizio
- Lin, Chang
- Takuma, Kazuhiro
- Wang, Ning
- Yan, Shirley ShiDu
- Wu, Hao
- ORCID
- Venue
- Science
- Published
- 2004-04-16
- Volume
- 304
- Issue
- 5669
- Pages
- 448-452
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2163757074
- Cited by
- 1,303
- References
- 22
- Citations by year
- 2026: 35 · 2025: 39 · 2024: 43 · 2023: 51 · 2022: 53 · 2021: 64 · 2020: 73 · 2019: 63 · 2018: 61 · 2017: 55 · 2016: 71 · 2015: 42 · 2014: 62 · 2013: 59 · 2012: 76
- FWCI
- 38.75
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute on Aging (AG-17490, AG 16736, K07AG000959, P50AG008702, P01AG017490, R01AG016736)
- National Institute of Neurological Disorders and Stroke (NS 42855, R01NS042855)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- Alzheimer's disease, amyloid-beta, alcohol dehydrogenase, mitochondrial toxicity, mitochondrial dysfunction, NAD+ binding, protein-protein interaction, oxidative stress, neuronal apoptosis, free radicals, memory impairment, therapeutic target
- MeSH terms
- Aged, Aged, 80 and over, Alzheimer Disease, Amino Acid Sequence, Animals, Binding Sites, Brain, Brain Chemistry, Carrier Proteins, Cells, Cultured, Cerebral Cortex, Crystallization, Hippocampus, Humans, Learning, Memory, Mice, Transgenic, Mitochondria, Models, Molecular, Molecular Sequence Data, Mutation, NAD, Neurons, Protein Binding, Protein Conformation, 3-Hydroxyacyl CoA Dehydrogenases, Amyloid beta-Peptides, Microscopy, Immunoelectron, Reactive Oxygen Species, Microscopy, Confocal, Mice, DNA Fragmentation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.